1. Binda C, Li M, Hubalek F, Restelli N, Edmondson DE, Mattevi A (2003) Insights into the mode of inhibition of human mitochondrial mono amine oxidase B from high resolution structures. Proc Natl Acad Sci USA 100(17):9750–9755
2. Chimenti F, Bolasco A, Manna F, Secci D, Chimenti P, Granese A, Bafeni O, Turini P, Cirilli R (2006) Synthesis, biological evaluation and 3D-QSAR of 1,3,5-trisubstituted-4,5-dihydro-(1H)-pyrazole derivatives as potent and highly selective monoamine oxidase A inhibitors. Curr Med Chem 13:1411–1428
3. Fava M (2001) Augmentation and combination strategies in treatment resistant depression. J Clin Psychiatry 62:4–11
4. Jazayeri S, Tehrani-Doost M, Keshavarz SA, Hosseini M, Djazayery A, Amini A, Jalali H, Peet M (2008) Comparision of therapeutic effects of omega-3-fatty acid eocosapentaenoic acid and fluoxetine, separately and in combination, in major depressive disorder. J Psychiatry 42:192–198
5. Jubie S, Shanish Antony A, Sikdar Pranabesh, Kalirajan R, Gomathy S, Gowramma B, Elango K (2011) Synthesis and biological evaluation of some Schiff bases of [4-(amino)-5-phenyl-l-4H-1,2,4-triazole-3-thiol. Pak J Pharm Sci 24–2:109–112